Knott David M Jr »

Adagio Therapeutics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2025-09-30 $110k 100k 1.10

More positions owned by Knott David M Jr

Calumet Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
Janus Henderson AAA CLO ETF Common (JAAA)
Darling Ingredients Common Call Option (DAR)
Xeris Biopharma Holdings Common (XERS)
Syndax Pharmaceutical Common (SNDX)
JPMorgan Chase & Co. Common (JPM)
Travere Therapeutics Common (TVTX)
Avadel Pharmaceuticals Common (AVDL)
Protagonist Therapeutics Common (PTGX)
Bridgebio Pharma Common (BBIO)
DocGo Common (DCGO)
Verona Pharma Common (VRNA)
LENZ Therapeutics Common (LENZ)

View all positions for Knott David M Jr

Top funds holding Adagio Therapeutics

Henderson Group
Maverick Capital
RA Capital Management
Point72 Asset Management
Mithril II GP
Vanguard Group
Driehaus Capital Management
M28 Capital Management
Eventide Asset Management
State Street Corporation
ADAR1 Capital Management
683 Capital Management
Redmile Group
Goldman Sachs Group
Eversept Partners

View all funds holding Adagio Therapeutics